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Role of Epigenetics in the ICSI and 
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Abstract
Paternal effects on the developmental potential of human embryos have been 
studied since the early 1990s, particularly with respect to newly emerging assisted 
reproduction technologies. Both genetic and epigenetic paternal effects can influ-
ence postfertilization development and cause implantation failure or miscarriage. 
However, it is only over the last few years that issues related to paternal effects 
associated with different assisted reproduction techniques on the health status of 
newborn and adult progeny have been focused. At the same time, new findings 
point out different, yet unexplored, areas of research into the potentially responsi-
ble factors, including the activity of the sperm-derived oocyte-activating factor and 
the oocyte signaling pathways mediating its action, the methylation status of both 
imprinted and non-imprinted genes, correct replacement of sperm nuclear prot-
amines with oocyte-derived histones, the histone acetylation status, and the func-
tion of sperm-borne small RNAs. It is increasingly important to know how these 
developmentally important epigenetic regulators can be altered in the context of 
the current micromanipulation-assisted fertilization techniques, intracytoplasmic 
sperm injection (ICSI) and round spermatid injection (ROSI). Last but not least, 
transgenerational transmission of acquired, environmentally conditioned disorders 
from fathers to offspring is a newly emerging issue which warrants further research.
Keywords: paternal effects, embryonic health, fetal health, offspring health, 
epigenetics, ICSI, ROSI, assisted reproduction, epigenetic inheritance
1. Introduction
There are two types of paternal factors involved in problems of embryonic, fetal 
and offspring health: the genetic ones and the epigenetic ones. The terms “hard” 
and “soft” inheritance, first introduced in 1980 [1], are increasingly used to refer to 
the genetic and epigenetic inheritance, respectively [2, 3]. These terms reflect very 
nicely the nature of the two kinds of inheritance. The genetic inheritance, the hard 
one, is based on transmission of DNA sequences, and it is this type of inheritance 
which has been the main subject of human genetic studies for the past 60 years. On 
the other hand, a number of studies carried out over the past 20 years have revealed 
that phenotypes are affected by more complex layers of information besides DNA 
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sequences. These factors, interposed between the DNA sequence of a gene and 
its phenotypic expression, are termed epigenetic marks and can be modified by 
environmental exposures [4].
This chapter reviews the current knowledge about the factors affecting epi-
genetic marks in human gametes and embryos and about the ways how improper 
function of the male gametes during the process of fertilization can influence 
further embryonic and fetal development, with particular attention to possible 
adverse epigenetic effects related to the new micromanipulation-assisted fertiliza-
tion technologies, intracytoplasmic sperm injection (ICSI) and round spermatid 
injection (ROSI).
2. Hard and soft hereditary elements
Hard hereditary elements are stable DNA sequences constituting specific genes 
that can only be modified by mutations or deletions. The system of soft hereditary 
elements is made up by a variety of molecules (epigenetic factors) that interact with 
each other and determine if, and to what extent, individual genes will be expressed 
at any given time of life. Early studies into epigenetic regulations in mammals largely 
focused on two constitutive events: genomic imprinting [5, 6] and X chromosome 
inactivation [7, 8]. However, later studies have pointed out that epigenetic regulation 
is a much more ample phenomenon than thought previously, involving a number of 
both imprinted and non-imprinted genes, and their role is particularly important in 
developmental processes, such as embryogenesis and organogenesis [9].
DNA methylation at the 5′ position of cytosin in CpG dinucleotides [2, 10] 
and histone acetylation are the two most widely known processes involved in 
epigenetic regulations. However, more recent studies have revealed other players in 
these complex processes, especially non-coding RNAs (siRNAs, microRNAs, and 
 piRNAs) [11–18], some of which have been detected in the germline [14, 15, 17, 18], 
as well as factors regulating higher-level organization of chromatin [19, 20]. Some 
of these elements can be modified by environmental factors leading to alternate 
gene expression [18–20].
3. Gamete and embryo epigenetics
In spite of the ample knowledge about epigenetic mechanisms involved in gene 
expression control during the early embryogenesis fetal development and adult 
life [9], the environmental epigenetic inheritance through gametes was initially 
thought impossible because of the belief that all epigenetic marks, including DNA 
methylation, histone acetylation status and small RNAs, are completely erased and 
subsequently reset during germline reprogramming [21]. In mammals, these events 
take place both in the germline and in zygote immediately after fertilization [21, 
22]. However, it is now known that this reset is not complete, and some parental 
imprinted loci can resist the global demethylation after fertilization, owing to the 
action of different mechanisms [23–26]. These findings explain previous observa-
tions on transgenerational transmission of environmentally conditioned disorders. 
For instance, the incidence of effects of parental ionizing irradiation on genomic 
instability in the offspring is too high to be explained by radiation-induced muta-
tions which occur at a substantially lower rate [27]. Epigenetic inheritance through 
gametes can also explain transgenerational transmission of obesity [28, 29], diabetes 
[30, 31], and some types of cancer [32, 33].
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All these data converge to suggest that epigenetic marks carried by the fertil-
izing spermatozoon are important for a variety of physiological and pathological 
processes that can affect offspring throughout life.
4. Potential sources of paternal epigenetic issues
It has been known since the early 2000 that human embryonic development 
is subject to paternal effects that can affect not only the early postfertilization 
events but also later phases of preimplantation and postimplantaion develop-
ment [34–36]. Two types of paternal effects were distinguished: the early 
paternal effect and the late paternal effect [35]. The early paternal effect was 
reflected by an impairment of postfertilization development as early as the 
1-cell zygote stage and subsequently was often associated with irregular cleav-
age divisions and blastomere fragmentation [34]. The late paternal effect was 
not detectable during the early cleavage stages, but became manifest after the 
8-cell stage [35, 36]. Unlike the early paternal effect, the late paternal effect was 
often, though not always, associated with abnormally increased levels of DNA 
fragmentation in the father’s sperm [35]. Both types of paternal effect reduced 
the chance of pregnancy [36].
In view of more recent data about sperm epigenetics, the meaning of these early 
observations can now be extended and reinterpreted. Since both the early and the 
late paternal effect were evaluated only in patients treated by intracytoplasmic 
sperm injection (ICSI), facilitating fertilization with spermatozoa carrying differ-
ent morphological and functional abnormalities, which would not be capable of 
fertilizing oocytes by their proper means, the analysis of the resulting embryos can 
yield valuable information about the impact of sperm abnormalities and immatu-
rity on fertilization and early development.
4.1 Fertilization with abnormal spermatozoa
ICSI has made it possible to achieve fertilization, embryonic and fetal devel-
opment and childbirth by using spermatozoa with severe morphological and 
functional abnormalities. However, these abnormalities cannot be blamed for 
most of the negative paternal effects observed in ICSI-derived embryos. In fact, 
data have shown that fertilization with spermatozoa from certain individuals 
consistently leads to the formation of embryos with developmental abnor-
malities detectable as early as the 1-cell zygote stage [34]. Interestingly, these 
 abnormalities almost always included abnormal pattern of the formation of 
nucleolar precursor bodies (NPBs) in the zygote pronuclei [34], as character-
ized previously [37]. The process of NPB assembly in human zygotes requires 
an early onset of RNA synthesis activity in the adjacent chromatin regions [38, 
39]. The nature of the RNA molecules synthesized at this stage is unknown, but 
they are likely to be non-coding ones, since the first signs of embryonic gene 
 expression can only be detected between the 4-cell and the 8-cell stage of the 
human preimplantation development [40–42]. These non-coding RNA species 
may be involved in the early epigenetic events that condition further embry-
onic development. Interestingly, the assembly of NPBs and the accompanying 
 pronuclear RNA synthesis coincide with the assembly of microtubule organizing 
centers in human zygotes [43], and abnormalities of NPB assembly are associated 
with abnormal development of human preimplantation embryos [37, 44] and an 
increased risk of embryo aneuploidy [45].
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Some conditions potentially responsible for sperm epigenetic abnormalities, 
such as advanced paternal age [46], tobacco smoking [47], and various lifestyle 
factors including dietary habits, physical activity or alcohol consumption [48], have 
been pointed out. However, a more comprehensive analysis of factors involved in 
these phenomena remains a big challenge for future research.
4.2 Fertilization with immature male germ cells
The final stage of sperm maturation is achieved during sperm passage through 
the epididymis. However, spermatozoa recovered directly from the testis [49, 50] 
and even round spermatids [51–55] are able to fertilize human oocytes and generate 
normal offspring when incorporated into oocytes via ICSI and ROSI, respectively. 
Moreover, live offspring was born in mice after fertilization with secondary sper-
matocytes [56], and in humans after fertilization with round spermatids developed 
in vitro from germ cells of men with spermatogenic arrest at the primary spermato-
cyte stage [57, 58].
Recent reports on the postnatal development of 108 babies born after fer-
tilization of oocytes by round spermatid injection (ROSI), 90 of them in Japan 
and 18 in Spain [59], did not show any significant differences as compared with 
naturally conceived babies in either physical or cognitive development during 
the first 2 years after birth, and none of them developed any of the syndromes 
associated with genomic imprinting defects [59]. Thus, the use of immature male 
germ cells for fertilization, in spite of the still relatively low success rates, does 
not appear to be associated with an increased risk of epigenetic abnormalities in 
the offspring.
4.3 Disorders of paternally induced oocyte activation
As discussed in the previous sections, human embryonic development appears 
to be particularly sensitive to epigenetic events taking place during an early phase 
of the fertilization process, referred to as oocyte activation. Oocyte activation has 
been extensively studied since the mid-1990s, especially in relation with the new 
technologies. Both ICSI and ROSI avoid the initial contact between the surfaces of 
the fertilizing spermatozoon and the oocyte preceding their fusion during natural 
fertilization. Yet, this contact activates a series of signal transduction events that 
participate in physiological oocyte activation [60, 61].
These early signal transduction events are obviously by-passed when oocytes 
are fertilized by ICSI. This shortcut, however, does not prevent fertilization in most 
mammalian species. In fact, sperm-induced oocyte activation is driven by repeated 
rises of free cytosolic Ca2+ ions, referred to as calcium oscillations, mediated by 
periodic release and uptake of calcium by two types of calcium stores (basically 
endoplasmic reticulum), one opened by inositol trisphosphate (IP3) and the other 
by the very increase in free cytosolic calcium in its  vicinity [62, 63]. In order to 
sustain the periodic calcium oscillations, the oocyte’s calcium stores have to be 
sensitized by a soluble factor released from the fertilizing spermatozoon, initially 
called “oscillin” and later identified as a special form of phospholipase C (PLC) 
referred to as PLCζ [64]. Even in the absence of the initial contact between the 
sperm and oocyte surfaces, the release of PLCζ from the injected spermatozoon to 
the oocyte cytoplasm, together with an early extracellular calcium influx produced 
by the ICSI procedure itself, is sufficient to sustain calcium oscillations needed for 
proper oocyte activation [65]. However, the temporal pattern of the oscillations 
after ICSI (Figure 1) is slightly different from that following sperm-oocyte fusion 
(Figure 2). The release of PLCζ from the spermatozoon to the oocyte cytoplasm 
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marks the spatial pattern of the first calcium rise, which propagates in a wave-like 
manner from the sperm position site across the oocyte (Figure 3).
Figure 1. 
Oscillations of free cytosolic Ca2+ concentration induced by sperm-oocyte fusion, recorded by confocal 
microscopy in a living human oocyte loaded with fluorescent calcium indicator Fluo-3 as described [65].
Figure 2. 
Oscillations of free cytosolic Ca2+ concentration after ICSI (arrow), recorded by confocal microscopy in a living 
human oocyte loaded with fluorescent calcium indicator Fluo-3 as described [65].
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In spite of the fact that the slight difference in the temporal pattern of the first 
sperm-induced calcium rise does not appear to have any impact on zygote and 
embryo development, the frequency and duration of the ongoing calcium rises have 
been shown to affect embryo development in different mammalian species [66–68] 
including the human [69]. Recent findings have pointed out the possibility that 
inherent abnormalities of the sperm-born PLCζ, but also in the oocyte response 
mechanisms, including steps downstream of the calcium releasing machinery, may 
influence mitotic divisions and gene expression during subsequent development 
and have to be considered an additional epigenetic risk factors to be taken into 
consideration in relation with the current-assisted fertilization technologies [70].
5. Current clinical experience
Several studies have suggested that both IVF and ICSI may increase the risk of cer-
tain types of birth defects in general [71–73] and heart defects in particular [74, 75]. 
However, there does not appear to exist a significant difference between the children 
conceived by conventional IVF and by ICSI [76, 77]. During the early years of its use, 
ICSI was preferentially employed in cases of poor sperm quality, while conventional 
IVF was used in cases with normal or nearly normal sperm, and the lack of significant 
differences between the outcomes of conventional IVF and ICSI suggests that sperm 
quality, as reflected by spermogram, spermocytogram and other standard sperm 
evaluation methods, has little, if any, impact on the health of offspring. Hence, the 
trend toward a higher risk of birth defects after IVF and ICSI as compared with natu-
ral conception is likely to be related to different, largely sperm-independent factors, 
such as the underlying cause of infertility, higher maternal age or a higher incidence 
of twin pregnancies [75, 78].
Even though there is no strong correlation between the conventional sperm 
parameters and ICSI outcome, sperm abnormalities, especially morphological ones, 
were shown to be associated with different genetic and epigenetic abnormalities 
[79], such as increased sperm DNA fragmentation [80] or abnormal patterns of 
DNA methylation [81]. Morphological abnormalities of the human sperm head 
Figure 3. 
Spatial propagation of the first sperm-induced increase in free cytosolic Ca2+ concentration, recorded by confocal 
microscopy in a living human oocyte loaded with fluorescent calcium indicator Fluo-3 as described [65].
7Paternal Effects on Embryonic, Fetal and Offspring Health: The Role of Epigenetics in the ICSI…
DOI: http://dx.doi.org/10.5772/intechopen.88589
have been shown to be associated with different types of genetic abnormalities 
[79], increased sperm DNA fragmentation [80] and different potentially harmful 
epigenetic factors, such as abnormal patterns of DNA methylation [81] and the 
absence or defective function of the sperm-derived oocyte-activating factor [82]. 
These observations explain the findings of increased implantation and pregnancy 
rate and decreased miscarriage rate [83–85], as well as a significantly decreased risk 
of major birth defects [86, 87], with the use of high-magnification ICSI (IMSI) as 
compared with conventional ICSI, although some studies failed to confirm these 
differences [88, 89].
As to fertilization by ICSI with immature (testicular) spermatozoa and by round 
spermatid injection (ROSI), the initial fears that incomplete or defective DNA 
methylation and chromatin configuration of these immature germ cells might cause 
syndromes related to genomic imprinting abnormalities [90] were not confirmed. 
In fact, no increase in the frequency of health problems caused by genomic imprint-
ing abnormalities, such as Beckwith-Wiedemann, Prader-Willi, and Angelman 
syndromes, has been detected in children born after ICSI with testicular sper-
matozoa [91] and ROSI [59]. A recent study [92] has suggested that the supposed 
increase of imprinting errors, present in the sperm of infertile patients, does not 
have an obvious influence on assisted reproduction outcome or the imprinting of 
offspring, probably because the imprinting errors in sperm are selectively discarded 
or corrected during development [20, 93].
In contrast to the reassuring clinical data concerning the potential epigenetic 
risk of using abnormal and immature male germ cells for fertilization, there is 
increasing concern about the possible transmission of epigenetic abnormalities and 
diseases acquired during the father’s life via his spermatozoa. This risk is difficult 
to evaluate with the use of currently available diagnostic methods because it is not 
necessarily associated either with sperm morphology or with its DNA integrity. It 
was actually demonstrated in humans that nutritional status and physical activity 
levels were associated with dynamic epigenetic changes in spermatozoa, includ-
ing DNA methylation patterns and small RNA expression [94–97]. This kind of 
acquired epigenetic changes in spermatozoa is suspected to mediate transgenera-
tional epigenetic inheritance of neurological disorders [95] and susceptibility to 
diabetes [31] and obesity [96, 97], and this list does not appear to be definitive, 
since new evidence of environmentally driven sperm-borne epigenetic factors, 
which are capable of altering the phenotype of the next generation, is emerging on 
a large scale. Paternal aging [46] and smoking [47] were also shown to affect sperm 
DNA methylation patterns, with still ill-defined developmental and health conse-
quences for the offspring.
6. Future prospects for paternal epigenetic diagnosis and treatment
Abnormal patterns of sperm DNA methylation, small RNA expression, and 
chromatin configuration can now be detected with a relative ease. However, many 
of these abnormalities lack clinical significance because they might be corrected 
during fertilization and postfertilization development. The mechanisms responsible 
for this repair are still largely hypothetical and poorly understood. However, they 
are very likely to exist because a recent publication, based on the analysis of 1280 
IVF-related treatment cycles, did not show any influence of either male age or 
sperm parameters on clinical pregnancy and live birth outcomes [92], in spite of the 
existence of data suggesting that there are very clear consequences of aging in the 
sperm epigenome that can be directly detected in DNA methylation patterns [46]. 
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Obviously, further studies are needed to assess whether any effects of male age and 
sperm parameters on the offspring health status can be detected later in life.
In order to be able to distinguish between “benign” paternal epigenetic altera-
tions that can be repaired spontaneously, on the one hand, and clinically relevant 
alterations that can cause negative effects on the embryonic, fetal and offspring 
health, studies are needed to relate DNA methylation status of specific genes and 
the expression pattern of specific small RNAs with specific developmental abnor-
malities. This work can be done by analyzing nucleic acids extracted directly from 
sperm cells or by using the “liquid biopsy” approach, based on the use of soluble 
nucleic acids isolated from blood plasma or seminal fluid. This latter approach is 
particularly interesting in azoospermic men so as to avoid the need for testicular 
biopsy to obtain a sample.
The identification of the developmentally relevant sperm epigenetic abnor-
malities is a necessary pre-requisite to design possible therapeutic interventions. 
These may go from relatively simple to more complex ones. It has been shown in 
the mouse that several waves of microRNAs and tRNA fragments are shipped to 
sperm during post-testicular maturation in the epididymis [98]. If some pathogenic 
paternal epigenetic signals are conveyed to sperm essentially during epididymal 
passage, ICSI with spermatozoa retrieved surgically from the testis, the technique 
already used with success in men with elevated levels of sperm DNA fragmentation 
[99, 100], might be a relatively simple and immediately available solution. If this 
approach is not possible, other, more sophisticated technologies, such as injecting 
specific microRNA molecules, capable of repairing specific epigenetic defects, into 
the early zygote [98] or induction of DNA methylation of the genes of interest by a 
Dnmt3-type de novo DNA methyltransferase targeted to the corresponding sperm 
DNA sequence by a nuclease-inactivated CRISPR variant (dCas9) [101], may be 
explored.
7. Conclusions
Since the availability of cell micromanipulation technologies enabling fertiliza-
tion of human oocytes by ICSI with immature (testicular) spermatozoa and by 
round spermatid injection (ROSI), the role of paternal factors on embryonic, fetal, 
and offspring health needed a profound revision. While genetic abnormalities 
contributed by injected spermatozoa or spermatids can be controlled by preim-
plantation genetic testing and usually lead to a miscarriage, sperm-borne epigenetic 
abnormalities are much more difficult to detect and may be at the origin of different 
health problems throughout the offspring life. The current knowledge of the origin, 
nature, and mechanism of action of these sperm-borne epigenetic factors is outlined 
in this chapter. Surprisingly, in spite of multiple types of sperm epigenetic abnormal-
ities associated with defective spermatogenesis and male aging, the current clinical 
experience is reassuring. In fact, no significant increase in the prevalence of diseases 
attributable to abnormal genomic imprinting was detected in children conceived by 
testicular spermatozoa or spermatids, probably because of the existence of efficient 
repair mechanisms acting in postfertilization stages of development.
By contrast, there is increasing evidence suggesting that transgenerational 
inheritance of paternally acquired epigenetic abnormalities via spermatozoa is more 
frequent than previously thought and can occur even in cases with normal conven-
tional sperm parameters and during natural conception. The known pathologies 
transmitted in this way include neurological disorders, obesity, and diabetes, and 
their list is in continuous expansion. Future diagnostic and therapeutic possibilities 
applicable in these cases are discussed.
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